ArrowMark Colorado Holdings LLC trimmed its position in shares of Mirion Technologies, Inc. (NYSE:MIR – Free Report) by 51.8% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 809,220 shares of the company’s stock after selling 868,292 shares during the period. ArrowMark Colorado Holdings LLC owned about 0.32% of Mirion Technologies worth $18,822,000 at the end of the most recent reporting period.
Several other hedge funds have also recently added to or reduced their stakes in MIR. Wolff Wiese Magana LLC purchased a new position in Mirion Technologies in the third quarter worth approximately $26,000. Salomon & Ludwin LLC purchased a new stake in shares of Mirion Technologies in the 3rd quarter valued at approximately $30,000. Fortress Investment Group LLC purchased a new stake in shares of Mirion Technologies in the 2nd quarter valued at approximately $32,000. EverSource Wealth Advisors LLC raised its holdings in shares of Mirion Technologies by 470.1% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,642 shares of the company’s stock valued at $35,000 after purchasing an additional 1,354 shares in the last quarter. Finally, Farther Finance Advisors LLC lifted its position in shares of Mirion Technologies by 96.5% during the 3rd quarter. Farther Finance Advisors LLC now owns 1,651 shares of the company’s stock worth $38,000 after purchasing an additional 811 shares during the last quarter. Institutional investors and hedge funds own 78.51% of the company’s stock.
Wall Street Analyst Weigh In
MIR has been the subject of a number of analyst reports. JPMorgan Chase & Co. lowered their target price on shares of Mirion Technologies from $33.00 to $30.00 and set an “overweight” rating for the company in a research note on Monday, March 9th. Evercore assumed coverage on Mirion Technologies in a research note on Tuesday, November 25th. They issued an “outperform” rating and a $29.00 price target on the stock. The Goldman Sachs Group decreased their price target on Mirion Technologies from $33.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, February 12th. Citigroup dropped their price objective on Mirion Technologies from $32.00 to $29.00 and set a “buy” rating on the stock in a report on Thursday, February 12th. Finally, Morgan Stanley cut their target price on Mirion Technologies from $29.00 to $27.00 and set an “equal weight” rating on the stock in a research report on Wednesday. Seven research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $27.63.
Mirion Technologies Stock Performance
NYSE MIR opened at $18.64 on Friday. The stock has a market capitalization of $4.67 billion, a price-to-earnings ratio of 169.49 and a beta of 0.99. The business’s 50 day moving average is $23.55 and its two-hundred day moving average is $23.99. Mirion Technologies, Inc. has a 12-month low of $12.00 and a 12-month high of $30.28. The company has a current ratio of 2.83, a quick ratio of 2.34 and a debt-to-equity ratio of 0.62.
Mirion Technologies (NYSE:MIR – Get Free Report) last posted its quarterly earnings results on Tuesday, February 10th. The company reported $0.15 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.01). Mirion Technologies had a net margin of 3.11% and a return on equity of 6.97%. The business had revenue of $277.40 million during the quarter, compared to analyst estimates of $281.17 million. During the same period in the prior year, the business earned $0.17 earnings per share. The firm’s quarterly revenue was up 9.1% compared to the same quarter last year. Mirion Technologies has set its FY 2026 guidance at 0.500-0.570 EPS. Research analysts expect that Mirion Technologies, Inc. will post 0.39 EPS for the current year.
Mirion Technologies Profile
Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.
Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.
Read More
- Five stocks we like better than Mirion Technologies
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- Unlocked: Elon Musk’s Next Big IPO
- A personal warning from Martin Weiss (Please read)
Receive News & Ratings for Mirion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mirion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
